Portal de Periódicos da CAPES

Severe adverse cardiovascular effects of pulse steroid therapy: Is continuous cardiac monitoring necessary?

1994; Elsevier BV; Volume: 30; Issue: 5 Linguagem: Inglês

10.1016/s0190-9622(08)81508-3

1097-6787

Kathleen Pogue White, Marcia S. Driscoll, Marti Jill Rothe, Jane M. Grant‐Kels,

Intraoperative Neuromonitoring and Anesthetic Effects

Pulse steroid therapy (PST) has been used in dermatology to treat a variety of severe inflammatory disorders. Dermatologists have usually recommended that patients be hospitalized for continuous cardiac monitoring during PST administration, although specialists in other fields have administered PST in an outpatient setting. We reviewed the literature concerning serious adverse cardiovascular effects of PST. These were rare and have been mainly reported in nondermatologic patients, typically those with kidney or heart disease. Although outpatient administration of PST may be a safe practice for some dermatologic patients, we cannot make a firm recommendation without a prospective trial. Pulse steroid therapy (PST) has been used in dermatology to treat a variety of severe inflammatory disorders. Dermatologists have usually recommended that patients be hospitalized for continuous cardiac monitoring during PST administration, although specialists in other fields have administered PST in an outpatient setting. We reviewed the literature concerning serious adverse cardiovascular effects of PST. These were rare and have been mainly reported in nondermatologic patients, typically those with kidney or heart disease. Although outpatient administration of PST may be a safe practice for some dermatologic patients, we cannot make a firm recommendation without a prospective trial.